Influx Healthtech Stock Price Analysis and Quick Research Report. Is Influx Healthtech an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Influx Healthtech. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Influx Healthtech has a PE ratio of 33.9043231259526 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Influx Healthtech has ROA of 24.0972% which is a good sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Influx Healthtech has a Current ratio of 1.445.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Influx Healthtech has a ROE of 45.3663%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Influx Healthtech has a Debt to Equity ratio of 0.0061 which means that the company has low proportion of debt in its capital.

• Sales growth: Influx Healthtech has reported revenue growth of 4.8903% which is poor in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Influx Healthtech for the current financial year is 19.6229603724046%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Influx Healthtech is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Influx Healthtech is Rs 5.7736. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Influx Healthtech in Ticker for free. Also, one can get the intrinsic value of Influx Healthtech by using Valuation Calculators, which are available with a Finology ONE subscription. 

Influx Healthtech FAQs

Q1. What is Influx Healthtech share price today?
Ans: The current share price of Influx Healthtech is Rs 195.75.

Q2. What is the market capitalisation of Influx Healthtech?
Ans: Influx Healthtech has a market capitalisation of Rs 453.16908 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Influx Healthtech?
Ans: The PE ratio of Influx Healthtech is 33.9043231259526 and the P/B ratio of Influx Healthtech is 4.84089947992789, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Influx Healthtech share?
Ans: The 52-week high share price of Influx Healthtech is Rs 208, and the 52-week low share price of Influx Healthtech is Rs 120.

Q5. Does Influx Healthtech pay dividends?
Ans: Currently, Influx Healthtech does not pay dividends. Dividend yield of Influx Healthtech is around 0%.

Q6. What are the face value and book value of Influx Healthtech shares?
Ans: The face value of Influx Healthtech shares is Rs 10, while the book value per share of Influx Healthtech is around Rs 40.4367. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Influx Healthtech?
Ans: Influx Healthtech has a total debt of Rs 0.2192 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Influx Healthtech?
Ans: The ROE of Influx Healthtech is 45.3663% and ROCE of Influx Healthtech is 60.1462%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Influx Healthtech a good buy for the long term?
Ans: The Influx Healthtech long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Influx Healthtech undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Influx Healthtech appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Influx Healthtech’s financials?
Ans: You can review Influx Healthtech’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.